ACCELERON PHARMA INC. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows, 20 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-07-09: Reporting owner CELGENE CORP /DE/ | BRISTOL MYERS SQUIBB CO; Form 4; Security Option Warrant; Transaction X Exercise of in-the-money or at-the-money derivative security.
- 2016-12-07: Reporting owner George Jean; Form 4; Security Warrants to Purchase Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-12-07: Reporting owner MCGUIRE TERRANCE; Form 4; Security Warrant (Right to Buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
- 2016-12-07: Reporting owner MCGUIRE TERRANCE; Form 4; Security Warrant (Right to Buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-07-09 | CELGENE CORP /DE/ | BRISTOL MYERS SQUIBB CO 10% Owner | 10% Owner | 4 | Option Warrant Derivative · Direct | X Exercise of in-the-money or at-the-money derivative security | −38,979 0 owned after | $5.88 exercise price | 2020-07-13 | |
| 2016-12-07 | George Jean Director | 4 | Warrants to Purchase Common Stock Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −127,122 0 owned after | $5.88 exercise price | 2016-12-19 | |
| 2016-12-07 | MCGUIRE TERRANCE Director | 4 | Warrant (Right to Buy) Derivative · Indirect · See Footnote | X Exercise of in-the-money or at-the-money derivative security | −180,518 0 owned after | $5.88 exercise price | 2016-12-09 | |
| 2016-12-07 | MCGUIRE TERRANCE Director | 4 | Warrant (Right to Buy) Derivative · Indirect · See Footnote | X Exercise of in-the-money or at-the-money derivative security | −3,384 0 owned after | $5.88 exercise price | 2016-12-09 | |
| 2013-09-19 holding as of filing | ATV Entrepreneurs VII, L.P. 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-19 | ||
| 2013-09-18 holding as of filing | Advanced Technology Ventures VII(B), L.P. | Advanced Technology Ventures VI, L.P. | ATV Alliance 2003, L.P. | ATV Entrepreneurs VI, L.P. | ATV Associates VII, L.L.C. | ADVANCED TECHNOLOGY VENTURES VII LP | ATV Associates VI, L.L.C. | Advanced Technology Ventures VII(C), L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | ORBIMED CAPITAL GP II LLC | ORBIMED ADVISORS LLC | ISALY SAMUEL D 10% Owner | 10% Owner | 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnote | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | ORBIMED CAPITAL GP II LLC | ORBIMED ADVISORS LLC | ISALY SAMUEL D 10% Owner | 10% Owner | 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnote | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | ORBIMED CAPITAL GP II LLC | ORBIMED ADVISORS LLC | ISALY SAMUEL D 10% Owner | 10% Owner | 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnote | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | ORBIMED CAPITAL GP II LLC | ORBIMED ADVISORS LLC | ISALY SAMUEL D 10% Owner | 10% Owner | 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnote | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | Venrock Partners, L.P. | Venrock Partners Management, LLC | VENROCK ASSOCIATES IV L P | VENROCK ENTREPRENEURS FUND IV L P | VEF Management IV, LLC | Venrock Management IV, LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Indirect · By Funds | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | EVNIN ANTHONY B Director, 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Indirect · By Funds | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | MCGUIRE TERRANCE Director | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnotes | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | GORDON CARL L Director | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnotes | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | GORDON CARL L Director | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnotes | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | GORDON CARL L Director | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnotes | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | GORDON CARL L Director | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnotes | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | POLARIS VENTURE PARTNERS IV LP | POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LP | Polaris Venture Management Co IV LLC 10% Owner | 10% Owner | 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | George Jean Director | 3 | Warrants to Purchase Common Stock Derivative · Indirect · See footnotes | Holding | $5.88 exercise price | 2013-09-18 | ||
| 2013-09-18 holding as of filing | CELGENE CORP /DE/ 10% Owner | 3 | Warrants to Purchase Common Stock Derivative · Direct | Holding | $5.88 exercise price | 2013-09-18 |